Table 2.
Equilibrium and kinetic parameters for the binding reaction of WT and R212A CYP3A4 with ritonavir and its analogs.
DAR
|
DTMCR
|
Ritonavir
|
||||
---|---|---|---|---|---|---|
WT | R212A | WT | R212A | WT | R212A | |
Ksa, μM | 0.5 ± 0.1 | 2.2 ± 0.2 | 3.6 ± 0.2 | 6.6 ± 0.4 | 0.05 ± 0.01b | 0.064 ± 0.008 |
Kdc, μM | –d | – | 0.16 ± 0.04 | – | – | – |
kfaste, s−1 | 0.29 ± 0.03 | 0.15 ± 0.02 | 1.0 ± 0.1 | 0.70 ± 0.03 | 1.4 ± 0.2 | 1.1 ± 0.2 |
kslowf, s−1 | 0.07 ± 0.01 | 0.030 ± 0.002 | 0.13 ± 0.02 | 0.07 ± 0.01 | 0.19 ± 0.03 | 0.22 ± 0.02 |
Spectroscopic dissociation constant.
Determined previously [7].
Kinetic dissociation constants.
Kd cannot be determined because of non-hyperbolic binding kinetics.
Rate constants in the fast and slow phases, respectively, determined at a maximal ligand concentration (18 μM).